Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (PACTR202607757570833) titled 'A clinical study to evaluate the effects of NXT007 compared to factor VIII prophylaxis in people with Hemophilia A' on July 31.
Study Type: Interventional
Study Design:
Parallel: different groups receive different interventions at same time during study,Randomised,Simple randomization using a randomization table created by a computer software program,Allocation Sequence/Code was not concealed
Primary Sponsor: F. Hoffmann La Roche Ltd
Condition:
Haematological Disorders
Haematological Disorders
Intervention:
NXT007
Recruitment Status: Not Recruiting
Phase: Phase-3
Date of First Enrollment: 31/07/202...